Interstitial cystitis-critical assessment of current treatment and opportunities for nanodelivery (Record no. 17319)

000 -LEADER
fixed length control field a
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220825100559.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220825b xxu||||| |||| 00| 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency AIKTC-KRRC
Transcribing agency AIKTC-KRRC
100 ## - MAIN ENTRY--PERSONAL NAME
9 (RLIN) 17584
Author Haq, Afzal Asif
245 ## - TITLE STATEMENT
Title Interstitial cystitis-critical assessment of current treatment and opportunities for nanodelivery
250 ## - EDITION STATEMENT
Volume, Issue number Vol.56(3), Jul-Sep
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Karnataka
Name of publisher, distributor, etc. Association of Pharmaceutical Teachers of India (APTI)
Year 2022
300 ## - PHYSICAL DESCRIPTION
Pagination 636-645p.
520 ## - SUMMARY, ETC.
Summary, etc. The characteristic feature of Interstitial cystitis (IC) or bladder pain syndrome is augmented,
pressure, or inconvenience in the suprapubic or bladder region. The causative factors for
IC are not completely understood however certain underlying disease condition may
trigger the pain. The therapy is aimed to provide symptomatic relief, and therefore, the
treatment protocols have been established based on experience. Intravesical delivery of
drugs has been well explored and found to be most effective in minimizing the symptoms
of IC without systemic adverse events. However, the efficacy of drug absorption is
limited by the bladder wall permeability and poor absorption of the instilled drugs. The
intravesical approach should be coupled with novel nanocarriers such as nanoparticles
or liposomes to overcome these limitations. Nanoparticles can easily cross the bladder
permeability barrier and enhance the drug retention time in the bladder, making the delivery
efficient and promising. This review addresses the current IC management strategies,
new potential therapeutic agents of natural origin, and various drugs undergoing clinical
trials by different routes of administration.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
9 (RLIN) 4639
Topical term or geographic name entry element PHARMACEUTICS
700 ## - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 8814
Co-Author Nair, Anroop
773 0# - HOST ITEM ENTRY
International Standard Serial Number 0019-5464
Title Indian journal of pharmaceutical education and research
Place, publisher, and date of publication Bengluru Association of Pharmaceutical Teachers of India (APTI)
856 ## - ELECTRONIC LOCATION AND ACCESS
URL https://ijper.org/sites/default/files/IndJPhaEdRes-56-3-636_0.pdf
Link text Click here
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Koha item type Articles Abstract Database
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Permanent Location Current Location Shelving location Date acquired Barcode Date last seen Price effective from Koha item type
          School of Pharmacy School of Pharmacy Archieval Section 2022-08-25 2022-1363 2022-08-25 2022-08-25 Articles Abstract Database
Unique Visitors hit counter Total Page Views free counter
Implemented and Maintained by AIKTC-KRRC (Central Library).
For any Suggestions/Query Contact to library or Email: librarian@aiktc.ac.in | Ph:+91 22 27481247
Website/OPAC best viewed in Mozilla Browser in 1366X768 Resolution.

Powered by Koha